1. Home
  2. MCB vs WVE Comparison

MCB vs WVE Comparison

Compare MCB & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metropolitan Bank Holding Corp.

MCB

Metropolitan Bank Holding Corp.

HOLD

Current Price

$98.48

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$5.85

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCB
WVE
Founded
1999
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
MCB
WVE
Price
$98.48
$5.85
Analyst Decision
Buy
Strong Buy
Analyst Count
3
16
Target Price
$98.67
$29.81
AVG Volume (30 Days)
137.7K
3.1M
Earning Date
04-21-2026
04-28-2026
Dividend Yield
1.13%
N/A
EPS Growth
11.64
N/A
EPS
2.92
N/A
Revenue
$11,053,000.00
$3,704,000.00
Revenue This Year
$37.22
N/A
Revenue Next Year
$14.75
$85.67
P/E Ratio
$34.60
N/A
Revenue Growth
N/A
149.43
52 Week Low
$64.66
$5.02
52 Week High
$102.04
$21.73

Technical Indicators

Market Signals
Indicator
MCB
WVE
Relative Strength Index (RSI) 54.70 44.59
Support Level $86.38 $5.48
Resistance Level $102.04 $6.48
Average True Range (ATR) 2.49 0.32
MACD -0.16 -0.01
Stochastic Oscillator 49.34 34.54

Price Performance

Historical Comparison
MCB
WVE

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: